Adaptimmune focuses on designing and delivering novel cancer immunotherapy products, utilizing the body’s own T-cells to target and destroy cancer
Adaptimmune focuses on designing and delivering novel cancer immunotherapy products, utilizing the body’s own T-cells to target and destroy cancer. They have developed a proprietary T-cell receptor (TCR) platform for identifying cancer targets and genetically engineering TCRs to attack these targets.